Three structured entry points — each designed to deliver immediate, measurable value while building toward a comprehensive AI governance posture. All engagements are scoped to your regulatory context and organizational maturity.
Structured 2–6 week assessment across USDM’s six AI maturity dimensions. Interviews, system inventory, gap analysis, and a prioritized 90-day roadmap — delivered as an executive briefing, board-ready and actionable from day one.
Regulatory gap analysis (FDA + EU AI Act + ISO 42001)
Build the compliance infrastructure your AI portfolio requires. USDM develops the TRUST-AI governance framework, SOP suite, risk classification system, and governance committee charter — fully audit-ready and aligned to FDA, EU AI Act, and GAMP 5.
Ongoing embedded AI governance — vendor assessments, TPRM monitoring, policy maintenance, regulatory horizon scanning, and AI risk committee support. Scales with your portfolio without requiring internal FTE investment.
60-minute executive alignment call — current AI landscape, regulatory exposure, priority pain points, and organizational readiness. No commitment required. USDM scopes a fixed-fee assessment proposal within 5 business days.
Structured stakeholder interviews, AI system inventory (including shadow AI discovery), gap analysis against FDA CSA + EU AI Act + ISO 42001, and use case scoring across six maturity dimensions.
Board-ready briefing: maturity scorecard, risk exposure summary, prioritized use case pipeline, and 12-month governance roadmap with resource and investment estimates.
Based on findings, initiate either the structured Governance Foundation build-out or transition directly to AI Governance as a Service for ongoing compliance management. Both include PoC delivery for top-priority use cases.
30 minutes. No commitment. Executive-level conversation about your AI governance posture and the fastest path to compliant adoption.